Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147


Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection.

Martins VP, Morais SB, Pinheiro CS, Assis NR, Figueiredo BC, Ricci ND, Alves-Silva J, Caliari MV, Oliveira SC.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2750. doi: 10.1371/journal.pntd.0002750. eCollection 2014 Mar.


Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.

Figueiredo BC, Assis NR, Morais SB, Ricci ND, Pinheiro CS, Martins VP, Bicalho RM, Da'dara AA, Skelly PJ, Oliveira SC.

PLoS Negl Trop Dis. 2014 Aug 21;8(8):e3107. doi: 10.1371/journal.pntd.0003107. eCollection 2014 Aug.


Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection.

Martins VP, Pinheiro CS, Figueiredo BC, Assis NR, Morais SB, Caliari MV, Azevedo V, Castro-Borges W, Wilson RA, Oliveira SC.

Clin Dev Immunol. 2012;2012:962538. doi: 10.1155/2012/962538. Epub 2012 Aug 15.


Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.

Farias LP, Cardoso FC, Miyasato PA, Montoya BO, Tararam CA, Roffato HK, Kawano T, Gazzinelli A, Correa-Oliveira R, Coulson PS, Wilson RA, Oliveira SC, Leite LC.

PLoS Negl Trop Dis. 2010 Feb 9;4(2):e597. doi: 10.1371/journal.pntd.0000597.


Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.

Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, de Melo AL, Caliari MV, Almeida GT, Venancio TM, Verjovski-Almeida S, Oliveira SC.

PLoS Negl Trop Dis. 2008 Oct 1;2(10):e308. doi: 10.1371/journal.pntd.0000308.


Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.

Ahmad G, Zhang W, Torben W, Haskins C, Diggs S, Noor Z, Le L, Siddiqui AA.

Parasitol Res. 2009 Nov;105(6):1767-77. doi: 10.1007/s00436-009-1646-z. Epub 2009 Oct 7.


Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.

Molehin AJ, Sennoune SR, Zhang W, Rojo JU, Siddiqui AJ, Herrera KA, Johnson L, Sudduth J, May J, Siddiqui AA.

Parasitol Res. 2017 Nov;116(11):3175-3188. doi: 10.1007/s00436-017-5634-4. Epub 2017 Oct 12.


DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.

Gonçalves de Assis NR, Batistoni de Morais S, Figueiredo BC, Ricci ND, de Almeida LA, da Silva Pinheiro C, Martins Vde P, Oliveira SC.

PLoS One. 2015 May 5;10(5):e0125075. doi: 10.1371/journal.pone.0125075. eCollection 2015.


Immunization with newly transformed Schistosoma mansoni schistosomula tegument elicits tegument damage, reduction in egg and parasite burden.

Teixeira de Melo T, Michel de Araujo J, Do Valle Durães F, Caliari MV, Oliveira SC, Coelho PM, Fonseca CT.

Parasite Immunol. 2010 Nov-Dec;32(11-12):749-59. doi: 10.1111/j.1365-3024.2010.01244.x.


Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.

El Ridi R, Tallima H.

Vaccine. 2009 Jan 29;27(5):666-73. doi: 10.1016/j.vaccine.2008.11.039. Epub 2008 Dec 3.


Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.

Ricciardi A, Dalton JP, Ndao M.

Vaccine. 2015 Jan 3;33(2):346-53. doi: 10.1016/j.vaccine.2014.11.016. Epub 2014 Nov 21.


Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.

Ahmad G, Torben W, Zhang W, Wyatt M, Siddiqui AA.

Parasite Immunol. 2009 Mar;31(3):156-61. doi: 10.1111/j.1365-3024.2008.01091.x.


Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.

Zhang W, Ahmad G, Torben W, Noor Z, Le L, Damian RT, Wolf RF, White GL, Chavez-Suarez M, Podesta RB, Kennedy RC, Siddiqui AA.

J Infect Dis. 2010 Apr 1;201(7):1105-12. doi: 10.1086/651147.


Protective and anti-pathology effects of Sm fructose-1,6-bisphosphate aldolase-based DNA vaccine against schistosoma mansoni by changing route of injection.

Saber M, Diab T, Hammam O, Karim A, Medhat A, Khela M, El-Dabaa E.

Korean J Parasitol. 2013 Apr;51(2):155-63. doi: 10.3347/kjp.2013.51.2.155. Epub 2013 Apr 25.


Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens.

El Ridi R, Tallima H, Mahana N, Dalton JP.

Microbes Infect. 2010 Sep;12(10):700-9. doi: 10.1016/j.micinf.2010.04.012. Epub 2010 May 7.


Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine.

Romeih MH, Hassan HM, Shousha TS, Saber MA.

Acta Biochim Biophys Sin (Shanghai). 2008 Apr;40(4):327-38.


Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens.

Sulbarán G, Noya O, Brito B, Ballén DE, Cesari IM.

PLoS Negl Trop Dis. 2013 Jun 20;7(6):e2254. doi: 10.1371/journal.pntd.0002254. Print 2013.


Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse.

Zhang W, Ahmad G, Torben W, Siddiqui AA.

Parasite Immunol. 2010 Apr;32(4):252-8. doi: 10.1111/j.1365-3024.2009.01181.x.

Supplemental Content

Support Center